Renal replacement therapy in severe COVID-19 patients: Intermittent or continuous, the ongoing debate
Anaesth Crit Care Pain Med
.
2021 Apr;40(2):100839.
doi: 10.1016/j.accpm.2021.100839.
Epub 2021 Mar 18.
Authors
Eliott Gaudray
1
,
Frédérik Bélot-De Saint Léger
1
,
Pierre-Yves Cordier
2
Affiliations
1
Intensive Care Unit, Laveran Military Teaching Hospital, 34 Boulevard Laveran, 13384 Marseille, France.
2
Intensive Care Unit, Laveran Military Teaching Hospital, 34 Boulevard Laveran, 13384 Marseille, France. Electronic address: py.cordier@icloud.com.
PMID:
33746077
PMCID:
PMC7970751
DOI:
10.1016/j.accpm.2021.100839
No abstract available
Publication types
Letter
Comment
MeSH terms
Acute Kidney Injury*
COVID-19*
France
Humans
Renal Replacement Therapy
SARS-CoV-2